Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
HBM Holdings Ltd. (HK:2142)
HKEX:2142
HBM Holdings Ltd. (2142) Stock Price & Analysis
1 Followers
2142 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$1.01 - HK$2.03
Previous CloseHK$1.38
Volume983.00K
Average Volume (3M)1.88M
Market Cap
HK$1.05B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)6.0
Beta2.14
Next Earnings
Aug 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.23
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume1,877,451
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
HBM Holdings Ltd. News
PremiumCompany Announcements
HBM Holdings Resubmits Key Drug Application
PremiumCompany Announcements
HBM Holdings Unveils Board and Committee Structure
PremiumCompany Announcements
HBM Holdings Announces Board Reshuffle
PremiumCompany Announcements
HBM Holdings AGM Concludes with Resounding ApprovalsOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.19% Mutual Funds
0.16% Other Institutional Investors
99.65% Public Companies and
Individual Investors
2142 FAQ
What was HBM Holdings Ltd.’s price range in the past 12 months?
HBM Holdings Ltd. lowest stock price was HK$1.01 and its highest was HK$2.03 in the past 12 months.
What is HBM Holdings Ltd.’s market cap?
Currently, no data Available
When is HBM Holdings Ltd.’s upcoming earnings report date?
HBM Holdings Ltd.’s upcoming earnings report date is Aug 27, 2024 which is in 57 days.
How were HBM Holdings Ltd.’s earnings last quarter?
HBM Holdings Ltd. released its earnings results on Mar 28, 2024. The company reported HK$0.202 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.202.
Is HBM Holdings Ltd. overvalued?
According to Wall Street analysts HBM Holdings Ltd.’s price is currently Overvalued.
Does HBM Holdings Ltd. pay dividends?
HBM Holdings Ltd. does not currently pay dividends.
What is HBM Holdings Ltd.’s EPS estimate?
HBM Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HBM Holdings Ltd. have?
HBM Holdings Ltd. has 768,876,400 shares outstanding.
What happened to HBM Holdings Ltd.’s price movement after its last earnings report?
HBM Holdings Ltd. reported an EPS of HK$0.202 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.222%.
Which hedge fund is a major shareholder of HBM Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:2142
---
HBM Holdings Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.38%
12-Months-Change
Fundamentals
Return on Equity
21.46%
Trailing 12-Months
Asset Growth
-1.52%
Trailing 12-Months
Company Description
HBM Holdings Ltd.
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9022, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others.
---
Technical Analysis
Petro-king Oilfield Services Ltd.
―
China Lesso Group Holdings
―
Man King Holdings Limited
―
Clover Biopharmaceuticals Ltd.
―
---